TRPV1 and inflammatory bowel disease: These studies are of potential clinical applications as TRPA1/TRPV1 antagonism and desensitization are marked as promising therapeutic approaches for the alleviation of pain associated with IBD and caution may be exercised before employing these approaches as a therapeutic option for the same.